Astrana Health, Inc. (ASTH)
NASDAQ: ASTH · Real-Time Price · USD
46.41
+1.38 (3.06%)
At close: Jun 30, 2026, 4:00 PM EDT
46.41
0.00 (0.00%)
After-hours: Jun 30, 2026, 4:38 PM EDT
Astrana Health Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Astrana Health stock has a consensus rating of "Strong Buy" and an average price target of $47.11. The average 1-year stock price forecast is 1.51% higher than the current stock price, while the lowest is $41 (-11.66%) and the highest is $53 (+14.20%).
Price Target: $47.11 (+1.51%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Astrana Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 8 | 8 | 8 |
| Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Reiterates $53 | Buy | Reiterates | $53 | +14.20% | Jun 30, 2026 |
| BTIG | BTIG | Buy Reiterates $50 | Buy | Reiterates | $50 | +7.74% | Jun 2, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 1, 2026 |
| Barclays | Barclays | Buy Upgrades $37 → $50 | Buy | Upgrades | $37 → $50 | +7.74% | May 26, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 13, 2026 |
Financial Forecast
Revenue This Year
4.00B
from 3.18B
Increased by 25.82%
Revenue Next Year
4.38B
from 4.00B
Increased by 9.35%
EPS This Year
2.92
from 2.12
Increased by 37.57%
EPS Next Year
3.41
from 2.92
Increased by 16.78%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.1B | ||
| Avg | 4.0B | ||
| Low | 3.9B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 28.5% | ||
| Avg | 25.8% | ||
| Low | 24.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.99 | ||
| Avg | 2.92 | ||
| Low | 2.85 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 40.9% | ||
| Avg | 37.6% | ||
| Low | 34.3% |